Prof. Sir David Lane University of Dundee, UK and Institute of Molecular and Cell Biology, Singapore

David Lane is the Director of the Cancer Research UK Transformation Research Group at the University of Dundee, where he leads a research team studying human tumor suppressor gene function. Sir David is also the Founder and Chairman of the Scientific Advisory Board of Cyclacel, a Dundee based biotechnology company... read moredeveloping novel drugs for the treatment of cancer, which recently became listed on NASDAQ. Sir David is also Chair of the Biomedical Research Council in Singapore and works on a part-time basis for the charity, Cancer Research UK. He completed undergraduate and postgraduate degrees at University College London where he studied auto-immunity under the supervision of Avrion Mitchison. He is internationally recognized for his original discovery of the p53 protein SV40 T antigen complex and his research has become focused on this one particular gene because it is so often mutated in the common tumors. David Lane was knighted for his contribution to cancer research in the New Year honours list in January 2000.